QLTY Stock Recent News

The GMO U.S. Quality ETF is designed to generate total return by investing in high-quality U.S. equities. One thing that stands out about the top 10 holdings of QLTY is Nvidia is nowhere to be found. The real differentiator is Healthcare, which has a more than double weighting relative to the S&P 500.

The U.S. stocks appear expensive after investor mania surrounding artificial-intelligence interrupted the bursting of an initial market bubble that was deflating in 2022, according to GMO's Jeremy Grantham.

QLTY: Solid Active ETF Focused On Quality Companies

In a little less than two weeks, advisors will flock to sunny Miami for the annual Exchange conference. Content sessions this year offer advisors insight into growing their business models in unexpected ways, the macro and market environment of 2024, navigating the AI revolution, and more.

Goldman Sachs' brand new ETF Accelerator business is starting off strong with three well-known firms already on board to enter the ETF arena for the first time. GMO, Eagle Capital Management and Brandes Investment Partners all have filings in with the SEC for individual ETFs via the independent 2023 Series Trust.

Jeremy Grantham's GMO has filed with regulators to create its first ETF. The proposed fund will be actively managed and focus on high quality stocks.

Legendary investor Jeremy Grantham's GMO is planning to offer an exchange-traded fund that will invest in U.S. quality stocks, the firm's first ETF as it responds to demand in the wealth management industry.